Therapy results in five ALL-BFM studies since 1970: implications of risk factors for prognosis

Haematol Blood Transfus. 1987:30:139-46. doi: 10.1007/978-3-642-71213-5_21.
No abstract available

MeSH terms

  • Actuarial Analysis
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Child
  • Combined Modality Therapy
  • Germany, West
  • Humans
  • Leukemia, Lymphoid / drug therapy*
  • Leukemia, Lymphoid / mortality
  • Leukemia, Lymphoid / therapy
  • Prognosis
  • Remission Induction
  • Risk